Rivaroxaban thromboprophylaxis in high risk ambulatory cancer patients receiving systemic therapy: Results of a randomized clinical trial (CASSINI) Meeting Abstract
| Authors: | Khorana, A. A.; Soff, G. A.; Kakkar, A. K.; Vadhan-Raj, S.; Riess, H.; Wun, T.; Streiff, M. B.; Garcia, D. A.; Liebman, H. A.; Belani, C.; O'Reilly, E. M.; Patel, J. N.; Yimer, H. A.; Wildgoose, P.; Burton, P.; Vijapurkar, U.; Kaul, S.; Eikelboom, J.; McBane, R. D.; Bauer, K. A.; Kuderer, N. M.; Lyman, G. H. |
| Abstract Title: | Rivaroxaban thromboprophylaxis in high risk ambulatory cancer patients receiving systemic therapy: Results of a randomized clinical trial (CASSINI) |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837600002 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-120738 |
| Notes: | Meeting Abstract: LBA-1 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
